Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis
- PMID: 7406445
- DOI: 10.1002/ana.410080105
Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis
Abstract
We examined the time course of lymphocyte responsiveness to acetylcholine receptor (AChR) in rats with experimental autoimmune myasthenia gravis (EAMG). Rats were immunized with purified torpedo AChR. At intervals of one to eight weeks later, lymphocytes from the lymph nodes and spleen were cultured with purified torpedo AChR and rat muscle extract containing AChR. Lymphocyte responsiveness (stimulation index) was determined from uptake of 3H-labeled thymidine by the cultured cells. The response of lymphocytes to torpedo antigen began earlier and rose more rapidly than that to the homologous (rat) antigen. Lymph node cells responded more promptly than spleen lymphocytes. The stimulation indexes peaked at four to six weeks while antibodies to both antigen continued to rise. Delineation of this pattern of lymphocyte responsiveness sheds further light on the pathogenesis of the autoimmune response in EAMG and will be useful in the future design of immunotherapeutic strategies.
Similar articles
-
T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.Cell Immunol. 1993 Dec;152(2):394-404. doi: 10.1006/cimm.1993.1300. Cell Immunol. 1993. PMID: 8258147
-
Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.Eur J Immunol. 1995 May;25(5):1191-8. doi: 10.1002/eji.1830250509. Eur J Immunol. 1995. PMID: 7774622
-
Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.Neurobiol Dis. 2004 Jul;16(2):461-7. doi: 10.1016/j.nbd.2004.03.017. Neurobiol Dis. 2004. PMID: 15193302
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.Crit Rev Immunol. 2001;21(1-3):1-27. Crit Rev Immunol. 2001. PMID: 11642597 Review.
-
Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?Arch Immunol Ther Exp (Warsz). 2012 Feb;60(1):19-30. doi: 10.1007/s00005-011-0158-6. Epub 2011 Dec 8. Arch Immunol Ther Exp (Warsz). 2012. PMID: 22159475 Review.
Cited by
-
Immunopathology of acetylcholine receptors in myasthenia gravis.Springer Semin Immunopathol. 1982;5(4):389-412. doi: 10.1007/BF01857427. Springer Semin Immunopathol. 1982. PMID: 6761884 Review.
-
Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.Yale J Biol Med. 1987 Mar-Apr;60(2):169-77. Yale J Biol Med. 1987. PMID: 3495075 Free PMC article.
-
Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.Exp Neurol. 2015 Aug;270:18-28. doi: 10.1016/j.expneurol.2015.03.010. Epub 2015 Mar 18. Exp Neurol. 2015. PMID: 25796590 Free PMC article.
-
The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.Clin Exp Immunol. 1983 Mar;51(3):543-50. Clin Exp Immunol. 1983. PMID: 6851245 Free PMC article.
-
Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.Acta Neuropathol. 1984;63(2):131-43. doi: 10.1007/BF00697195. Acta Neuropathol. 1984. PMID: 6610275
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical